Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BCI-137

Copy Product Info
😃Good
Catalog No. T23777Cas No. 112170-24-8
Alias BCI137

BCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA binding domain.

BCI-137

BCI-137

Copy Product Info
😃Good
Purity: 99.72%
Catalog No. T23777Alias BCI137Cas No. 112170-24-8
BCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA binding domain.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$39In StockIn Stock
5 mg$89In StockIn Stock
10 mg$127In StockIn Stock
25 mg$218In StockIn Stock
50 mg$323In StockIn Stock
100 mg$483In StockIn Stock
200 mg$689-In Stock
1 mL x 10 mM (in DMSO)$98In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.72%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

BCI-137 AI Summary
BCI-137 shows bioactivity in multiple assays, acting as an inhibitor with notable potencies. In an assay targeting inhibitors of Polymerase Iota, the compound exhibited a potency of 89,125.1 nM. Additionally, in a primary assay for delayed death inhibitors of the malarial parasite plastid, BCI-137 displayed a potency of 9,285.0 nM. Furthermore, it demonstrates a binding affinity to AGO2, as evidenced by a RIP assay, with a dissociation constant (Kd) of 126,000.0 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
BCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA binding domain.
SynonymsBCI137
Chemical Properties
Molecular Weight313.29
FormulaC11H11N3O6S
Cas No.112170-24-8
SmilesS(NC(C(O)=O)C)(=O)(=O)C=1C=C2C(=CC1)NC(=O)C(=O)N2
Relative Density.1.566 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 140 mg/mL (446.87 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.38 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1919 mL15.9597 mL31.9193 mL159.5965 mL
5 mM0.6384 mL3.1919 mL6.3839 mL31.9193 mL
10 mM0.3192 mL1.5960 mL3.1919 mL15.9597 mL
20 mM0.1596 mL0.7980 mL1.5960 mL7.9798 mL
50 mM0.0638 mL0.3192 mL0.6384 mL3.1919 mL
100 mM0.0319 mL0.1596 mL0.3192 mL1.5960 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BCI-137 | purchase BCI-137 | BCI-137 cost | order BCI-137 | BCI-137 chemical structure | BCI-137 formula | BCI-137 molecular weight